Skip to main content
. 2022 Mar 8;43(6):1311–1318. doi: 10.1007/s00246-022-02853-9

Table 4.

Outcome in relation to type of tachycardia

SVT mechanism N Still under prophylactic medicationa
N (%)
AVRT 47 11 (23)
AVNRT 1 1 (100)
FAT 15 4 (27)
Intrauterine SVT 17 10 (59)
No intrauterine SVT 46 6 (13)

FAT focal atrial tachycardia, AVNRT atrioventricular nodal re-entrant tachycardia, AVRT atrioventricular re-entrant tachycardia, SVT supraventricular tachycardia

aNo withdraw of medication possible or recurrence of SVT after cessation of medication